Pinealon

Description

Pinealon

Also known as: EDR, Glu-Asp-Arg

Pinealon is a synthetic tripeptide bioregulator composed of the amino acids glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg, or EDR). It was developed within the framework of the Khavinson peptide research initiative and has been primarily explored for its possible role in supporting cognitive function, protecting neural tissue, regulating circadian rhythms, enhancing neuronal resilience, and promoting healthy aging. Because of its low molecular weight, it has drawn scientific attention for its potential to modulate gene activity and influence cellular mechanisms in nervous system tissues.

Key areas of research include:
– Enhancement of memory and cognitive performance
– Support for neuronal protection and long-term brain cell health
– Regulation of sleep-wake cycles and circadian rhythms
– Contributions to longevity and age-related neurological health
– Influence on brain function and stress response systems

• Status: Approved for use in Russia – Not approved by the FDA. Evidence based on animal research.
• Standard dosage: 10–20 mg per day, usually taken once in the evening. Can be administered orally or sublingually.
• Investigated for: Supporting brain health, improving sleep, addressing cognitive decline associated with aging, and providing neuroprotective effects.